Focused shockwaves as a diagnostic stimulus in low-back pain · Single-group study · 2024
Can focused shockwave help pinpoint painful muscle spots in low back pain?
In this study of 28 adults with long-lasting low back pain, focused shockwave was aimed at muscle spots first found by touch. It very often made pain spread and usually brought on people's familiar pain, for example in 22 of 26 deep lower-back muscle spots. Treatment itself was not tested.
Explores shockwave for finding pain spots- adults with long-lasting low back pain
- 28
- muscle spots tested
- 115
- of 28 people had pain spread or felt familiar pain
- 27
Good to know: 28 people at one centre; each person could have several spots tested.
Müller-Ehrenberg H, Giordani F, Müller-Ehrenberg A, et al. Biomedicines, 2024 · Read the paper ↗
How this study worked
Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.
The treatment
Focused shockwave test
Focused
- Strength
- 0.06–0.30mJ/mm² (adjusted to what each person could tolerate) · 5 per second
- Numbing
- Not mentioned
- Device
- Wolf PiezoWave2 FB10 G10
Compared with: No comparison group; shockwave was used as a test, not a treatment
Settings are what each study used, not a prescription.
Who took part
28 adults (15 women, 13 men; average age 59) with long-lasting low back pain of no clear cause, recruited through a newspaper advertisement.
Side effects
Testing was meant to bring on pain, kept within what each person could tolerate. The paper gives no side-effect counts.
All the numbers and the full appraisal
Every reported result
The results, in numbers.
Twenty-eight adults with chronic nonspecific low-back pain were recruited by newspaper advertisement: 15 women, 13 men, mean age 59.0 years and mean symptom duration 87.39 months. Investigators selected 115 trigger-point/muscle observations; these are not 115 independent patients.
Participants; no attrition reported.
Pain referral1 reported outcome
Pain referral
Pain referral Selected muscle/trigger-point observations
Observed subgroup counts; these are not randomized treatment arms.
Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.
Analysis details and source
Muscle/site selections overlap within 28 people; bilateral responses separately recorded. Table headings say patients but text says 115 MTrPs. Counts are not independent people or diagnostic sensitivity.
Familiar pain recognition1 reported outcome
Familiar pain recognition
Familiar pain recognition Selected muscle/trigger-point observations
Observed subgroup counts; these are not randomized treatment arms.
Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.
Analysis details and source
Muscle/site selections overlap within 28 people; bilateral responses separately recorded. Table headings say patients but text says 115 MTrPs. Counts are not independent people or diagnostic sensitivity.
How treatment was delivered
Wolf PiezoWave2 FB10 G10 focused source, approximately 10-mm focal zone, 5 Hz and 0.06–0.30 mJ/mm² adjusted to verbal tolerance. Gel spacers placed the focus 3–5 cm deep for lumbar/gluteal targets or 1–3 cm for superficial targets. Total pulses per diagnostic point were not reported.
Pain was intentionally elicited and intensity adjusted to tolerance. No systematic adverse-event counts are provided. No external funding or conflicts were declared.
The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.
Source-linked critical reading
Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.
Technical source record
Full local PDF read; All 13 PDF pages; Methods and statistics; Tables 1–2; Figures1–5 and captions; Discussion limitations; conclusions; declarations; references
Focused stimulation often reproduced familiar or spreading pain at preselected sites. This early study does not prove that it identifies the true cause of back pain or that a positive response predicts treatment benefit.
Can focused shockwave stimulation of palpation-selected lumbar/gluteal/thigh trigger points reproduce familiar or referred pain?
Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.
Twenty-eight adults with chronic nonspecific low-back pain were recruited by newspaper advertisement: 15 women, 13 men, mean age 59.0 years and mean symptom duration 87.39 months. Investigators selected 115 trigger-point/muscle observations; these are not 115 independent patients.
Wolf PiezoWave2 FB10 G10 focused source, approximately 10-mm focal zone, 5 Hz and 0.06–0.30 mJ/mm² adjusted to verbal tolerance. Gel spacers placed the focus 3–5 cm deep for lumbar/gluteal targets or 1–3 cm for superficial targets. Total pulses per diagnostic point were not reported.
All tested sites were preselected using manual palpation by experienced clinicians. There was no randomized sham, asymptomatic control or blinded independent diagnostic reference.
Patients answered yes/no about referred pain and recognition of their familiar pain during stimulation. Bilateral sites could be recorded separately. Table 2 labels counts as patients, while Methods describe positive registrations per stimulated trigger point; this unit ambiguity is retained.
Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.
Pain was intentionally elicited and intensity adjusted to tolerance. No systematic adverse-event counts are provided. No external funding or conflicts were declared.
The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.
The technique may help describe familiar pain in selected chronic low-back-pain patients. It has not been shown to distinguish radiculopathy, determine surgical indications, prevent failed surgery or improve treatment outcomes.
Use independent blinded examiners, repeatability testing, prespecified reference diagnoses, asymptomatic and disease controls, patient-level clustered analyses and prospective diagnostic accuracy/management outcomes.
Read the original article.
The Use and Benefits of Focused Shockwaves for the Diagnosis of Myofascial Pain Syndrome by Examining Myofascial Trigger Points in Low Back Pain.
Müller-Ehrenberg H, Giordani F, Müller-Ehrenberg A, Stange R. · Biomedicines · 2024
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →